Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation.
Claudio GambardellaGuglielmo ClariziaRenato PatroneChiara OffiClaudio MaurielloRoberto RomanoMarco FilardoAlessandra ConzoAlessandro SanguinettiAndrea PolistenaNicola AveniaGiovanni ConzoPublished in: BMC surgery (2019)
In patients affected by breast cancer requiring axillary lymphnodes dissection, the use of advanced hemostasis devices is highly desirable. Among the non-traditional tools, Thunderbeat resulted to be superior in terms of reduction of intra-operative blood loss and post-operative drainage output, moreover associated to a substantial reduction of postoperative seroma incidence.
Keyphrases
- lymph node
- sentinel lymph node
- end stage renal disease
- ultrasound guided
- neoadjuvant chemotherapy
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- patients undergoing
- prognostic factors
- risk factors
- rectal cancer
- squamous cell carcinoma
- radiation therapy
- patient reported
- breast cancer risk
- locally advanced